An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

NCT01439360 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12046

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Quadrivalent seasonal influenza vaccine(Flu D-QIV) GSK2321138A
BIOLOGICAL: Havrix Junior
BIOLOGICAL: Prevenar 13
BIOLOGICAL: Varivax/ProVarivax
BIOLOGICAL: Varilrix

Sponsor

GlaxoSmithKline